GAPDH and Huntington disease: Our findings that Aβ42 and GAPDH persist as SDS-insoluble aggregates in the CSF of patients with AD and previous reports linking tTG to AD and Huntington disease pathology [12,32] prompted us to examine the possibility of tTG-mediated covalent interaction between the two polypeptides.